MCKENZIE HAMACHER: Open Payments
NPI 1962174375 · JEFFERSON CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,221 in 279 payments from 17 companies in 2025. Trend: 2023 $2,809 · 2024 $3,654 · 2025 $4,221
Food & beverage: $4,117Education: $103
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 90 | $1,094 |
| Aimmune Therapeutics, Inc. | 26 | $434 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $413 |
| Phathom Pharmaceuticals, Inc. | 23 | $348 |
| Janssen Biotech, Inc. | 18 | $321 |
| Ardelyx, Inc. | 17 | $304 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $229 |
| GENZYME CORPORATION | 9 | $228 |
| PFIZER INC. | 11 | $211 |
| Gilead Sciences, Inc. | 21 | $175 |
Products named: RINVOQ, ENTYVIO, VOQUEZNA, DUPIXENT, TREMFYA, IBSRELA, VOWST, LINZESS.
Industry payments across MO — which companies pay providers there.
